Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Shanghai Kaisai Biotechnology Co., Ltd. (hereinafter referred to as "Kaisai Biotechnology", 688065. SH) was established in 2000. It is a science and technology innovation board listed company based on synthetic biology and other disciplines, utilizing biological manufacturing technology to engage in the research and development, production, and sales of bio based new materials. Currently, the headquarters and research and development center are located in Zhangjiang High tech Park, Pudong, Shanghai; Three production bases are located in Jinxiang, Wusu, and Taiyuan (under construction). At present, Kaisai Biological's business mainly focuses on the polyamide industry chain, and its products include a series of bio based long chain dicarboxylic acids and bio based pentanediamines, which can be used as monomer raw materials for the production of bio aggregated amides, as well as a series of bio based polyamides and related products. The product can be widely used in various fields such as textiles, pharmaceuticals, spices, automobiles, electronic appliances, and daily consumer goods. Kaisai Biotechnology is the leading supplier of long-chain dicarboxylic acids for biological processes worldwide. In 2018, Kaisai Biological's biological long carbon chain dicarboxylic acid was awarded the title of single champion product in the manufacturing industry by the Ministry of Industry and Information Technology of the People's Republic of China and the China Federation of Industrial Economics. The bio based pentanediamine independently developed and produced by Kaisai Biological is widely used in epoxy curing agents, hot melt adhesives, isocyanates and other related fields. At the same time, replacing hexamethylene diamine with pentanediamine in the polyamide industry can not only solve the main bottleneck in the development of the domestic polyamide industry, but also contribute to the market Customers provide renewable biomass raw materials The new material of "bio manufacturing" can provide excellent performance derived from odd carbon for downstream bio based polyamides and other products. Based on the self produced bio based pentanediamine and different binary acid polycondensation, the bio based polyamide series products have the characteristics of flame retardancy, moisture absorption, easy dyeing, low warpage, high flow, as well as environmental protection and sustainability advantages. Based on the self produced bio based polyamide series products, Kaisai Biological has launched a high-performance textile material series Titan "can be widely used in fields such as textiles, clothing, carpets, and industrial silk. In addition, based on the excellent performance of the product such as high strength, high heat resistance, and good dimensional stability, Kaisai Biological has launched the engineering material "ECOPENT", which can be widely used in fields such as automobiles, electronics and electrical, industry, and consumer goods, providing solutions for sustainable development of society. In the future, Kaisai Biotechnology will continue to promote the iteration and innovation of bio based products and technologies around the four core technologies, providing positive driving force for the development of synthetic biology and biomanufacturing industries in China and even globally with its own efforts, and leading the sustainable development of technology and industry. |
Headquarter | Shanghai |
Establish Date | 11/24/2000 |
Listed Code | 688065.SH |
Listed Date | 8/12/2020 |
Chairman | XIUCAI LIU (Liu Xiucai). |
CEO | XIUCAI LIU (Liu Xiucai). |
Website | www.cathaybiotech.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial